Welcome to our dedicated page for Ecolab news (Ticker: $ECL), a resource for investors and traders seeking the latest updates and insights on Ecolab stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Ecolab's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Ecolab's position in the market.
Ecolab Inc. announced the election of twelve director nominees for a one-year term, approval of executive officers' compensation, and ratification of an accounting firm at its annual meeting. A stockholder proposal on an independent board chair policy was not approved. The final vote tabulation will be reported to the SEC.
Ecolab Inc. announced a regular quarterly cash dividend of $0.57 per common share, to be paid on July 15, 2024, to shareholders of record on June 18, 2024. This marks the 87th consecutive year of cash dividends being paid on Ecolab's common stock.
Ecolab Inc. reported very strong first-quarter performance with diluted EPS at $1.43 and adjusted diluted EPS at $1.34, a 52% increase. Sales grew by 5%, organic sales by 5%, and operating income margin by 13.8% to 14.7%. Ecolab has agreed to sell its global surgical solutions business for $950 million. The outlook for 2024 includes an adjusted diluted EPS range of $6.40 - $6.70, a 23% - 29% increase.